A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC).
文献类型：期刊论文
| 作者 | Wang, Jing; Lou, Hanmei; Cai, Hong-Bing; Huang, Xin; Li, Guiling; Wang, Li; Liu, Ting; Liu, Wei; Li, Baiyong; Xia, Yu |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| 资助项目 | Akeso |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000863680300217 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 资助机构 | Akeso |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129945]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Akeso Biopharma Inc, Zhongshan, Peoples R China 2.Hunan Canc Hosp, Changsha, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 4.Wuhan Univ, Dept Gynecol Oncol, Zhongnan Hosp, Wuhan, Peoples R China 5.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 6.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China 7.Henan Canc Hosp, Zhenzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wang, Jing,Lou, Hanmei,Cai, Hong-Bing,et al. A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC).[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Wang, Jing.,Lou, Hanmei.,Cai, Hong-Bing.,Huang, Xin.,Li, Guiling.,...&Xia, Yu.(2022).A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC)..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Wang, Jing,et al."A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC).".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。